Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Ранг среди акций #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Цена акции
$1.81
Последняя синхронизация: 2026-08-21
Рыночная капитализация
$77.00M
Изменение (1 день)
1.30%
Изменение (1 год)
-23.63%
Страна
US
Торговля Annovis Bio, Inc. (ANVS)

Категория

История дроблений акций Annovis Bio, Inc. (ANVS)
Акции Annovis Bio, Inc. (символ: ANVS) прошли через 0 дроблений.
Последнее дробление произошло Aug 22, 2026.
Одна акция ANVS, купленная до Aug 22, 2026, сейчас соответствует 0 акциям ANVS.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH